- Home
- MLYS vs VIRT Comparison
MLYS vs VIRT Comparison
Compare MLYS & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- VIRT
- Stock Information
- Founded
- MLYS 2019
- VIRT 2008
- Country
- MLYS United States
- VIRT United States
- Employees
- MLYS N/A
- VIRT N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- VIRT Investment Bankers/Brokers/Service
- Sector
- MLYS Health Care
- VIRT Finance
- Exchange
- MLYS Nasdaq
- VIRT Nasdaq
- Market Cap
- MLYS 2.9B
- VIRT 2.8B
- IPO Year
- MLYS 2023
- VIRT 2015
- Fundamental
- Price
- MLYS $40.40
- VIRT $35.19
- Analyst Decision
- MLYS Strong Buy
- VIRT Hold
- Analyst Count
- MLYS 6
- VIRT 7
- Target Price
- MLYS $46.40
- VIRT $41.43
- AVG Volume (30 Days)
- MLYS 1.5M
- VIRT 1.0M
- Earning Date
- MLYS 11-10-2025
- VIRT 10-29-2025
- Dividend Yield
- MLYS N/A
- VIRT 2.73%
- EPS Growth
- MLYS N/A
- VIRT 132.69
- EPS
- MLYS N/A
- VIRT 4.62
- Revenue
- MLYS N/A
- VIRT $2,694,104,000.00
- Revenue This Year
- MLYS N/A
- VIRT N/A
- Revenue Next Year
- MLYS N/A
- VIRT N/A
- P/E Ratio
- MLYS N/A
- VIRT $7.62
- Revenue Growth
- MLYS N/A
- VIRT 41.05
- 52 Week Low
- MLYS $8.24
- VIRT $31.89
- 52 Week High
- MLYS $47.65
- VIRT $45.77
- Technical
- Relative Strength Index (RSI)
- MLYS 49.69
- VIRT 53.16
- Support Level
- MLYS $36.56
- VIRT $34.28
- Resistance Level
- MLYS $47.65
- VIRT $36.27
- Average True Range (ATR)
- MLYS 3.45
- VIRT 0.91
- MACD
- MLYS -0.00
- VIRT 0.20
- Stochastic Oscillator
- MLYS 50.18
- VIRT 70.76
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.